1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Medical Writing Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Medical Writing Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Medical Writing Market Regional Analysis
6.2 North America Medical Writing Market Revenue 2021-2031 (US$ Million)
6.3 North America Medical Writing Market Forecast Analysis
7. North America Medical Writing Market Analysis – by Type
7.1 Clinical Writing
- 7.1.1 Overview
- 7.1.2 Clinical Writing: North America Medical Writing Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Regulatory Writing
- 7.2.1 Overview
- 7.2.2 Regulatory Writing: North America Medical Writing Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Scientific Writing
- 7.3.1 Overview
- 7.3.2 Scientific Writing: North America Medical Writing Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: North America Medical Writing Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Medical Writing Market Analysis – by Application
8.1 Medical Journalism
- 8.1.1 Overview
- 8.1.2 Medical Journalism: North America Medical Writing Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Medical Education
- 8.2.1 Overview
- 8.2.2 Medical Education: North America Medical Writing Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Medico Marketing
- 8.3.1 Overview
- 8.3.2 Medico Marketing: North America Medical Writing Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: North America Medical Writing Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Medical Writing Market Analysis – by End User
9.1 Pharmaceutical and Biotechnology Companies
- 9.1.1 Overview
- 9.1.2 Pharmaceutical and Biotechnology Companies: North America Medical Writing Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Contract Research Organizations
- 9.2.1 Overview
- 9.2.2 Contract Research Organizations: North America Medical Writing Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. North America Medical Writing Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Medical Writing Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 10.2.1.1 North America Medical Writing Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Medical Writing Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 US: North America Medical Writing Market Breakdown, by Type
- 10.2.1.1.2 US: North America Medical Writing Market Breakdown, by Application
- 10.2.1.1.3 US: North America Medical Writing Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Medical Writing Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Canada: North America Medical Writing Market Breakdown, by Type
- 10.2.1.2.2 Canada: North America Medical Writing Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Medical Writing Market Breakdown, by End User
- 10.2.1.3 Mexico:
North America Medical Writing Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Mexico: North America Medical Writing Market Breakdown, by Type
- 10.2.1.3.2 Mexico: North America Medical Writing Market Breakdown, by Application
- 10.2.1.3.3 Mexico: North America Medical Writing Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Cactus Communications
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Parexel International Corp
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Certara Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Freyr LLC
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Quanticate International Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 SIRO Clinpharm Pvt Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 ProPharma Group
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Caidya
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Wipro Ltd
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 SGS SA
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Laboratory Corp of America Holdings
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 TUNECT
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 Indegene Ltd
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 Evidera
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 Syner-G BioPharma Group
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments
13.16 EMTEX BV
- 13.16.1 Key Facts
- 13.16.2 Business Description
- 13.16.3 Products and Services
- 13.16.4 Financial Overview
- 13.16.5 SWOT Analysis
- 13.16.6 Key Developments
13.17 BioAgile Therapeutics Private Limited
- 13.17.1 Key Facts
- 13.17.2 Business Description
- 13.17.3 Products and Services
- 13.17.4 Financial Overview
- 13.17.5 SWOT Analysis
- 13.17.6 Key Developments
13.18 Tata Consultancy Services Ltd
- 13.18.1 Key Facts
- 13.18.2 Business Description
- 13.18.3 Products and Services
- 13.18.4 Financial Overview
- 13.18.5 SWOT Analysis
- 13.18.6 Key Developments
13.19 InClin
- 13.19.1 Key Facts
- 13.19.2 Business Description
- 13.19.3 Products and Services
- 13.19.4 Financial Overview
- 13.19.5 SWOT Analysis
- 13.19.6 Key Developments
13.20 TransPerfect Life Sciences
- 13.20.1 Key Facts
- 13.20.2 Business Description
- 13.20.3 Products and Services
- 13.20.4 Financial Overview
- 13.20.5 SWOT Analysis
- 13.20.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations